期刊
EMERGING INFECTIOUS DISEASES
卷 18, 期 1, 页码 120-124出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1801.110515
关键词
-
资金
- Canadian Institutes of Health Research
- Abbott Laboratories Ltd.
To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据